Heart failure is the leading cause of combined morbidity and mortality in the USA with 50% of cases being diastolic heart failure. Diastolic heart failure results from poor myocardial relaxation and inadequate filling of the left ventricular chamber caused in part by calcium-handling dysregulation. In this chapter we describe methods to investigate new approaches of novel human Ca 2+ binding protein motifs to restore normal Ca 2+ handling function to diseased myocardium. Gene transfer of parvalbumin into adult cardiac myocytes has been studied as a potential therapeutic, specifically as a strategic Ca 2+ buffer to correct cardiac mechanical dysfunction in disease. This chapter provides protocols for studying wild-type parvalbumin isoforms and parvalbumins with strategically designed EF-hand motifs in adult cardiac myocytes via acute adenoviral gene transfer. These protocols have been used extensively to optimize parvalbumin function as a potential therapeutic for failing heart muscle.
CITATION STYLE
Thompson, B. R., Cohen, H., Angulski, A. B. B., & Metzger, J. M. (2019). Gene transfer of calcium-binding proteins into adult cardiac myocytes. In Methods in Molecular Biology (Vol. 1929, pp. 187–205). Humana Press Inc. https://doi.org/10.1007/978-1-4939-9030-6_12
Mendeley helps you to discover research relevant for your work.